Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring

登录注册会员服务联系我们

Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring—author's reply

Published:2023-05-27 Issue:12 Volume:57 Page:1471-1472
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Fumery Mathurin¹^ORCID,Roblin Xavier²^ORCID

Affiliation:

1. Department of Gastroenterology Amiens University Hospital, and PeriTox, Université de Picardie Amiens France

2. Department of Gastroenterology St Etienne University Hospital St Etienne France

Abstract

LINKED CONTENTThis article is linked to Fumery et al papers. To view these articles, visit https://doi.org/10.1111//apt.17421 and https://doi.org/10.1111/apt.17439

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17514

Reference3 articles.

1. Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring

2. Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study

3. Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP